Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jacques Fieschi-Meric"'
Autor:
Jerome Galon, Aurelie Collignon, Alex Trinh, Marion Olive, Clémence Jaume, Maïté Chamourin, Nour Sfeir, Dylan Anselmo, Raana Ramouz-Charpentier, Georgia Culey, Christophe Haond, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ce515bad97d34972b4d29e0d2c75c7e6
Autor:
Noémie Resseguier, Julien Mazières, Fabrice Barlesi, Maurice Pérol, Thomas Sbarrato, Fanny Arnoux, Stéphane Garcia, Jacques Fieschi-Meric, Vanina Leca, Alboukadel Kassambara, Lamia Ghezali, Pernelle Outters, Christelle Cotteaux-Lautard, Florence Monville, Maryannick Le Ray, Marie Roumieux, Richard Malkoun, Arnaud Boyer, Louisiane Lebas, Hervé Pegliasco, Patricia Barré, Clarisse Audigier-valette, Sarah Zahi, Luc Odier, Stéphane Hominal, Laurent Greillier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/3b2736fc933c4d1c8782c09fa6c847bc
Autor:
Jerome Galon, Aurelie Collignon, Alex Trinh, Marion Olive, Clémence Jaume, Maïté Chamourin, Nour Sfeir, Dylan Anselmo, Raana Ramouz-Charpentier, Georgia Culey, Christophe Haond, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/b86738bfef834e5cb4e5ab9c3d5b6147
Autor:
Demerle Clemence, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Frederic Fiore, Geoffrey Guittard, Bernard Malissen, Herve Luche, Jacques Fieschi-Meric, Laurent Greillier, Fabrice Barslesi, Daniel Olive
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c65fa1b6a68e8e2a7108874f3c3bf01d
https://doi.org/10.1136/jitc-2022-sitc2022.1107
https://doi.org/10.1136/jitc-2022-sitc2022.1107
Autor:
Christophe Haond, Clémence Jaume, Dylan Anselmo, Georgia Culey, Raana Ramouz-Charpentier, Marion Olive, Aurélie Collignon, Nour Sfeir, Jérôme Galon, Maïté Chamourin, Alex Trinh, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCancer immunotherapy reinvigorates tumor-specific T cell responses of CD8+ cytotoxic T lymphocytes that detect intracellular antigens that are presented by MHC class I molecules expressed by all tumor cell types. Because most tumors do not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aadb2c3f00407d46849995479f90b70
https://doaj.org/article/ce515bad97d34972b4d29e0d2c75c7e6
https://doaj.org/article/ce515bad97d34972b4d29e0d2c75c7e6
Autor:
Vanina Leca, Alboukadel Kassambara, Lamia Ghezali, Pernelle Outters, Christelle Cotteaux-Lautard, Fanny Arnoux, Thomas Sbarrato, Florence Monville, Maryannick Le Ray, Marie Roumieux, Stephane Garcia, Richard Malkoun, Noémie Resseguier, Arnaud Boyer, Louisiane Lebas, Hervé Pegliasco, Patricia Barré, Clarisse Audigier-valette, Sarah Zahi, Luc Odier, Stéphane Hominal, Maurice Perol, Julien Mazieres, Laurent Greillier, Fabrice Barlesi, Jacques Fieschi-Meric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPD1/L1 Immune Checkpoint Inhibitors (ICI) have significantly improved long-term outcome in about 20% of advanced Non Small Cells Lung Cancer (NSCLC) patients (pts), but 80% present primary or secondary resistance. The PIONeeR project (NCT03
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da7b174201ee0960add2de3bc9946c4
https://doi.org/10.1136/jitc-2021-sitc2021.460
https://doi.org/10.1136/jitc-2021-sitc2021.460
Autor:
Alex Trinh, Jérôme Galon, Dylan Anselmo, Jacques Fieschi-Meric, Marion Olive, Clémence Jaume, Nour Sfeir, Maïté Chamourin, Christophe Haond, Raana Ramouz-Charpentier, Georgia Culey, Aurélie Collignon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundDensity and localization of T cells within the tumor microenvironment (TME) is critical to control tumor growth. Immunotherapy with antibodies against immune checkpoint inhibitors (ICI), which aim to reinvigorate exhausted T cells, despite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6210c830c0844ea2ee4a7d9b2b4a6f
https://doi.org/10.1136/jitc-2021-sitc2021.057
https://doi.org/10.1136/jitc-2021-sitc2021.057